Not a good buy right now for an impatient buyer: price is pressing into near-term resistance after a sharp move, while fundamentals and upcoming earnings risk skew downside.
Options positioning is bullish (calls dominate), but overall liquidity is thin and implied volatility is very elevated, which typically reflects uncertainty rather than “easy upside.”
With no fresh news catalysts and weakening recent quarterly performance, the risk/reward favors avoiding a new entry here.
Technical Analysis
Trend/Momentum: MACD histogram is positive (0.198) and expanding → momentum is currently bullish.
Activity: total volume 20 contracts (calls 19 / puts 1) → sentiment is bullish but based on thin flow.
Volatility: IV(30d) 74.02 vs historical vol 44.25; IV percentile 82.07 → options are priced for large moves/uncertainty.
Implication: traders are leaning bullish, but elevated IV + low liquidity makes the signal less reliable and suggests event/earnings risk is being priced in.
Bottom line: recent quarter shows slowing demand + profitability pressure, which weakens the case to buy aggressively at a near-term technical peak.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Most recent action (2025-11-06, Roth Capital): maintained Buy rating but cut price target to $40 from $50 after Q3.
What Wall St. pros like: still sees upside to the PT ($40 vs ~$35.45) and keeps a positive longer-term view.
What they’re cautious about: challenging conditions, tariffs/uncertainty impacting customer decisions, pressured product profitability, and limited forward visibility.
Net take: rating says “upside exists,” but the target cut and visibility concerns argue against buying impulsively at current levels.
Wall Street analysts forecast HY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HY is 36.5 USD with a low forecast of 33 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast HY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HY is 36.5 USD with a low forecast of 33 USD and a high forecast of 40 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 34.810
Low
33
Averages
36.5
High
40
Current: 34.810
Low
33
Averages
36.5
High
40
Roth Capital
Buy
downgrade
$50 -> $40
AI Analysis
2025-11-06
Reason
Roth Capital
Price Target
$50 -> $40
AI Analysis
2025-11-06
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Hyster-Yale to $40 from $50 and keeps a Buy rating on the shares after its Q3 results. Conditions stay challenging given the impact of market uncertainties and tariffs on both customer decision-making and underlying product profitability, as forward visibility looks much more limited currently, the analyst tells investors in a research note.
Northland
Ted Jackson
Market Perform
downgrade
$75 -> $50
2025-05-12
Reason
Northland
Ted Jackson
Price Target
$75 -> $50
2025-05-12
downgrade
Market Perform
Reason
Northland analyst Ted Jackson lowered the firm's price target on Hyster-Yale Materials to $50 from $75 and keeps a Market Perform rating on the shares. Hyster-Yale reported a "mixed" Q1 relative to consensus, says the analyst, who lowered FY25 forecasts because of tariffs and economic uncertainty.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for HY
